Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellia Therapeutics

13.60
+0.81506.38%
Post-market: 13.52-0.0750-0.55%19:51 EDT
Volume:4.12M
Turnover:54.96M
Market Cap:1.41B
PE:-2.61
High:13.71
Open:12.82
Low:12.73
Close:12.78
Loading ...
Jan 09, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Dec 16, 2019

Major Issues Report

Current report, item 8.01
Oct 31, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 31, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 26, 2019

Major Issues Report

Current report, item 8.01
Sep 10, 2019

Correspondence

[Cover]Correspondence
Sep 10, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 30, 2019

Correspondence

[Cover]Correspondence
Aug 08, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 06, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 02, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 09, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jun 04, 2019

Correspondence

[Cover]Correspondence
Jun 04, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 22, 2019

Major Issues Report

Current report, item 5.07
May 02, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 02, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]